DAFNA Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-430,291
| Closed | -$779K | – | 81 |
|
|
2023
Q2 | $779K | Sell |
430,291
-49,095
| -10% | -$88.9K | 0.21% | 56 |
|
|
2023
Q1 | $633K | Hold |
479,386
| – | – | 0.19% | 58 |
|
|
2022
Q4 | $810K | Hold |
479,386
| – | – | 0.23% | 56 |
|
|
2022
Q3 | $887K | Buy |
479,386
+28,281
| +6% | +$52.3K | 0.24% | 62 |
|
|
2022
Q2 | $1.39M | Buy |
451,105
+29,948
| +7% | +$91.9K | 0.38% | 54 |
|
|
2022
Q1 | $3.04M | Buy |
421,157
+187,657
| +80% | +$1.35M | 0.79% | 35 |
|
|
2021
Q4 | $3.82M | Sell |
233,500
-66,450
| -22% | -$1.09M | 0.96% | 30 |
|
|
2021
Q3 | $2.99M | Sell |
299,950
-50
| -0% | -$498 | 0.79% | 30 |
|
|
2021
Q2 | $2.99M | Hold |
300,000
| – | – | 0.63% | 39 |
|
|
2021
Q1 | $2.99M | Buy |
+300,000
| New | +$2.99M | 0.71% | 36 |
|